METROPOLIS

Metropolis Healthcare Limited

Diagnostics chain with pathology labs and specialty testing services across India

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

metropolisindia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹530.35
Market cap
11,009 Cr
Stock P/E
54.6
P/B
7.25
Dividend yield
0.2%
ROE (FY26)
12.5%
ROCE (FY26)
18.4%
Operating margin (FY26)
16.2%
Debt / equity (FY26)
0.01
OCF / EBITDA (FY26)
87.5%
OCF / EBITDA (3Y)
89.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Metropolis (Metropolis Healthcare) runs a network of diagnostic laboratories and collection centres across India that test samples for patients directly (B2C) and for hospitals, other labs and corporates (B2B).

Company snapshot

3rdBy market cap

Ranked among 10 companies in Healthcare Service Provider.

Segment mix

Reportable segments as of 2019-03-31 (Standalone). Revenue share = segment revenue ÷ total revenue.

Largest segment: 100.0% of revenue

SegmentRevenue shareRevenuePBTAssets
Other income
3.5%
21 Cr0 Cr—
Pathology services
100.0%
581 Cr149 Cr—

Shares add up to 104% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓89% of operating profit came in as cash over the last three years — profits are backed by real cash.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales309 Cr291 Cr331 Cr313 Cr350 Cr323 Cr345 Cr386 Cr429 Cr406 Cr425 Cr450 Cr
Operating expenses (approx.)234 Cr226 Cr251 Cr235 Cr260 Cr251 Cr283 Cr296 Cr321 Cr311 Cr317 Cr339 Cr
EBITDA75 Cr65 Cr80 Cr79 Cr90 Cr72 Cr62 Cr90 Cr108 Cr95 Cr108 Cr111 Cr
OPM %24.2%22.3%24.2%25.2%25.7%22.3%18.0%23.2%25.2%23.4%25.4%24.7%
Other income1 Cr2 Cr3 Cr2 Cr3 Cr3 Cr7 Cr8 Cr0.89 Cr9 Cr8 Cr5 Cr
Interest6 Cr5 Cr6 Cr5 Cr5 Cr5 Cr5 Cr5 Cr6 Cr6 Cr8 Cr6 Cr
Depreciation22 Cr25 Cr26 Cr26 Cr27 Cr28 Cr29 Cr31 Cr32 Cr32 Cr39 Cr32 Cr
Profit before tax48 Cr37 Cr51 Cr51 Cr61 Cr42 Cr36 Cr61 Cr71 Cr57 Cr70 Cr78 Cr
Tax %25.9%26.0%27.7%25.4%23.9%25.7%18.9%26.1%25.5%26.4%27.0%26.8%
Net profit36 Cr27 Cr37 Cr38 Cr47 Cr31 Cr29 Cr45 Cr53 Cr42 Cr51 Cr57 Cr
EPS (₹)₹6.92₹5.30₹7.11₹7.41₹9.08₹6.11₹5.69₹8.70₹10.17₹7.99₹2.46₹2.73

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales545 Cr644 Cr761 Cr856 Cr998 Cr1,228 Cr1,148 Cr1,208 Cr1,331 Cr1,646 CrSign in free for the trailing twelve months
Operating expenses (approx.)393 Cr471 Cr561 Cr624 Cr712 Cr886 Cr860 Cr925 Cr1,028 Cr1,245 CrSign in free for the trailing twelve months
EBITDA152 Cr173 Cr200 Cr233 Cr286 Cr343 Cr288 Cr283 Cr303 Cr401 CrSign in free for the trailing twelve months
OPM %27.9%26.8%26.3%27.2%28.7%27.9%25.1%23.4%22.8%24.4%Sign in free for the trailing twelve months
Other income23 Cr8 Cr8 Cr9 Cr12 Cr18 Cr15 Cr9 Cr15 Cr26 CrSign in free for the trailing twelve months
Interest0.39 Cr1 Cr0.53 Cr8 Cr8 Cr20 Cr27 Cr23 Cr19 Cr25 CrSign in free for the trailing twelve months
Depreciation17 Cr19 Cr20 Cr39 Cr46 Cr63 Cr89 Cr94 Cr109 Cr134 CrSign in free for the trailing twelve months
Profit before tax160 Cr160 Cr187 Cr169 Cr244 Cr293 Cr188 Cr175 Cr191 Cr259 CrSign in free for the trailing twelve months
Tax %32.9%31.5%33.7%24.4%25.0%26.8%23.5%26.5%23.8%26.2%Sign in free for the trailing twelve months
Net profit107 Cr110 Cr124 Cr128 Cr183 Cr215 Cr143 Cr128 Cr146 Cr191 CrSign in free for the trailing twelve months
EPS (₹)₹20.48₹20.61₹24.06₹25.36₹35.97₹41.87₹27.91₹24.95₹28.29₹9.19Sign in free for the trailing twelve months
Dividend payout %————22.3%19.1%28.6%16.0%12.7%10.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr41 Cr
Reserves314 Cr405 Cr409 Cr513 Cr696 Cr876 Cr978 Cr1,086 Cr1,321 Cr1,472 Cr
Borrowings0.77 Cr0.57 Cr18 Cr——259 Cr79 Cr—14 Cr19 Cr
Other liabilities170 Cr101 Cr115 Cr227 Cr296 Cr384 Cr432 Cr456 Cr519 Cr595 Cr
Total liabilities515 Cr530 Cr553 Cr752 Cr1,004 Cr1,530 Cr1,502 Cr1,555 Cr1,867 Cr2,138 Cr
Fixed assets (net)105 Cr112 Cr117 Cr121 Cr115 Cr139 Cr137 Cr156 Cr190 Cr215 Cr
CWIP0.95 Cr—6 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Investments136 Cr102 Cr33 Cr14 Cr10 Cr16 Cr15 Cr55 Cr71 Cr337 Cr
Loans & advances——15 Cr11 Cr4 Cr0.05 Cr0 Cr0 Cr0 Cr0 Cr
Inventories14 Cr21 Cr26 Cr24 Cr41 Cr51 Cr45 Cr39 Cr48 Cr45 Cr
Trade receivables80 Cr101 Cr137 Cr128 Cr123 Cr135 Cr122 Cr126 Cr148 Cr170 Cr
Cash & bank26 Cr43 Cr51 Cr107 Cr387 Cr66 Cr69 Cr63 Cr39 Cr55 Cr
Other assets153 Cr151 Cr167 Cr346 Cr325 Cr1,123 Cr1,114 Cr1,117 Cr1,371 Cr1,315 Cr
Total assets515 Cr530 Cr553 Cr752 Cr1,004 Cr1,530 Cr1,502 Cr1,555 Cr1,867 Cr2,138 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity102 Cr104 Cr90 Cr215 Cr249 Cr253 Cr247 Cr264 Cr263 Cr351 Cr
Cash from investing-86 Cr2 Cr35 Cr-105 Cr62 Cr-735 Cr47 Cr-89 Cr-201 Cr-223 Cr
Cash from financing-17 Cr-87 Cr-118 Cr-55 Cr-33 Cr163 Cr-292 Cr-181 Cr-87 Cr-115 Cr
Net cash flow-1 Cr19 Cr7 Cr55 Cr279 Cr-321 Cr3 Cr-6 Cr-24 Cr15 Cr
Free cash flow (OCF − Capex)86 Cr86 Cr66 Cr179 Cr221 Cr223 Cr194 Cr200 Cr194 Cr307 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %46.5%37.6%42.8%33.7%35.6%27.3%20.0%17.9%15.5%18.4%
ROE %29.5%23.8%28.6%24.2%25.9%24.1%14.4%11.6%10.9%12.5%
Debtor days54576555454039384038
Inventory days38535544596764586551
Days payable978890152160136135150171145
Cash conversion cycle-52230-54-56-29-32-53-65-56
OCF / EBITDA %67.0%60.2%45.0%92.3%87.1%73.9%85.7%93.5%86.7%87.5%
OCF / EBITDA % (3 years)——56.4%67.5%77.1%83.3%81.7%83.7%88.6%89.0%
Debt / equity0.00240.00140.04—0.000.290.08—0.010.01
Current ratio1.883.322.452.342.981.301.141.281.181.40
Net debt / EBITDA-0.16-0.25-0.17-0.46-1.350.560.04-0.22-0.08-0.09